OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention
Yangyang Feng, Tongyue Zhang, Yijun Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 71

Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux
Ye Zhang, Jian‐Ge Qiu, Wei Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
Ankita Sharma, Rafeeq Mir, Sanjeev Galande
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 52

HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression
Yan Zhang, Qiang Da, Siyi Cao, et al.
Circulation (2021) Vol. 144, Iss. 8, pp. 638-654
Open Access | Times Cited: 47

METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance
Zhang Ye, Jian‐Ge Qiu, Xiaoyu Jia, et al.
Cancer Letters (2022) Vol. 553, pp. 215971-215971
Closed Access | Times Cited: 33

Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112335-112335
Open Access | Times Cited: 33

HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target
Fan Fan, Haoyang Mo, Hao Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113800-113800
Open Access | Times Cited: 22

The KDM5A/HOXA5 axis regulates osteosarcoma progression via activating the Wnt/β-catenin pathway
Yi Luo, Youzhi He, Yuxia Xu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access

Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization
Xiao Zheng, Nan Hu, Jiamin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023)
Closed Access | Times Cited: 10

Molecular implications of HOX genes targeting multiple signaling pathways in cancer
U Sangeetha Shenoy, Divya Adiga, Shama Prasada Kabekkodu, et al.
Cell Biology and Toxicology (2021) Vol. 38, Iss. 1, pp. 1-30
Open Access | Times Cited: 22

HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/β-Catenin Pathway
Hongmei Ma, Qian Zhang, Xuemei Yang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 15

HPV16 integration regulates ferroptosis resistance via the c-Myc/miR-142-5p/HOXA5/SLC7A11 axis during cervical carcinogenesis
Xiaojing Chen, Chu-Hong Guo, Yang� Yang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Circ_0109046 promotes the malignancy of endometrial carcinoma cells through the microRNA‐105/SOX9/Wnt/β‐catenin axis
Yanyan Li, Jinyu Liu, Jinxia Piao, et al.
IUBMB Life (2020) Vol. 73, Iss. 1, pp. 159-176
Open Access | Times Cited: 21

Epigenetic Dysregulation of the Homeobox A5 (HOXA5) Gene Associates with Subcutaneous Adipocyte Hypertrophy in Human Obesity
Luca Parrillo, Rosa Spinelli, Mattia Costanzo, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 728-728
Open Access | Times Cited: 13

HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway
Fei Xiong, Wenzheng Liu, Xin Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 12

Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma
Xiulin Jiang, Chunyan Wang, Jishu Guo, et al.
Aging (2022) Vol. 14, Iss. 6, pp. 2819-2854
Open Access | Times Cited: 11

PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma
Sijia Ge, Hua Huang, Wei Huang, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 885-895
Open Access | Times Cited: 11

Deregulation of miR-375 Inhibits HOXA5 and Promotes Migration, Invasion, and Cell Proliferation in Breast Cancer
Rajesh Kannan Moorthy, Chandhru Srinivasan, Maheshkumar Kannan, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 7, pp. 4503-4523
Closed Access | Times Cited: 5

HOXA5 Is Recognized as a Prognostic-Related Biomarker and Promotes Glioma Progression Through Affecting Cell Cycle
Fengqin Ding, Ping Chen, Pengfei Bie, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12

Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer
Xiao Yu, Zhaoshuo Li, Ruihua Bai, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 12516-12531
Open Access | Times Cited: 9

The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction
Luca Parrillo, Rosa Spinelli, Michele Longo, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2090-2090
Open Access | Times Cited: 4

Hoxa5 Inhibits the Proliferation and Induces Adipogenic Differentiation of Subcutaneous Preadipocytes in Goats
Dingshuang Chen, Yaqiu Lin, Nan Zhao, et al.
Animals (2022) Vol. 12, Iss. 14, pp. 1859-1859
Open Access | Times Cited: 7

A small molecule compound 759 inhibits the wnt/beta-catenin signaling pathway via increasing the Axin protein stability
Seunghan Sun, Young‐Dae Gong, Jong Soon Kang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top